Literature DB >> 9648874

Nitric oxide-induced release of acetylcholine in the nucleus accumbens: role of cyclic GMP, glutamate, and GABA.

H Prast1, M H Tran, H Fischer, A Philippu.   

Abstract

We have previously shown that the basal acetylcholine release in the ventral striatum is under the enhancing influence of endogenous nitric oxide (NO) and that NO donors cause pronounced increases in the acetylcholine release rate. To investigate the role of cyclic GMP, glutamate, and GABA in the NO-induced acetylcholine release, we superfused the nucleus accumbens, (Nac) of the anesthetized rat with various compounds through a push-pull cannula and determined the neurotransmitter released in the perfusate. Superfusion of the Nac with the NO donors diethylamine/NO (DEANO; 100 micromol/L), S-nitroso-N-acetylpenicillamine (SNAP; 200 micromol/L), or 3-morpholinosydnonimine (SIN-1; 200 micromol/L) enhanced the acetylcholine release rate. The guanylyl cyclase inhibitor 1H-(1,2,4)-oxodiazolo(4,3-a)quinoxalin-1-one (ODQ; 10 micromol/L) abolished the effects of DEANO and SIN-1. 6-(Phenylamino)-5,8-quinolinedione (LY-83583; 100 micromol/L), which also inhibits cyclic GMP synthesis, inhibited the releasing effects of DEANO and of SNAP, whereas the effect of SIN-1 on acetylcholine release was not influenced. The DEANO-induced release of acetylcholine was also abolished in the presence of 20 micromol/L 6,6-dinitroquinoxaline-2,3-dione (DNQX) and 10 micromol/L (+/-)-2-amino-5-phosphonopentanoic acid (AP-5). Simultaneous superfusion with 50 micromol/L quinpirole and 10 micromol/L 7-bromo-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SKF 83566) was ineffective. Superfusion with 500 micromol/L DEANO decreased the release of acetylcholine. The inhibitory effect of 500 micromol/L DEANO was reversed to an enhanced release on superfusion with 20 micromol/L bicuculline. Bicuculline also enhanced the basal release rate. These findings indicate that cyclic GMP mediates the NO-induced release of acetylcholine by enhancing the outflow of glutamate. Dopamine is not involved in this process. Only high concentrations of NO increase the output of GABA, which in turn decreases acetylcholine release. Our results suggest that cells that are able to release glutamate, such as glutamatergic neurons, are the main target of NO in the Nac.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648874     DOI: 10.1046/j.1471-4159.1998.71010266.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

Review 1.  Nitric oxide and the pancreas: morphological base and role in the control of the exocrine pancreatic secretion.

Authors:  M D Yago; M Mañas; Z Ember; J Singh
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

Review 2.  Nitric oxide (NO) and obstructive sleep apnea (OSA).

Authors:  James S J Haight; Per Gisle Djupesland
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

3.  Nitrergic modulation of hippocampal acetylcholine release is independent of endothelial NO synthase activity.

Authors:  Marie-Luise Buchholzer; Jochen Klein
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

4.  Differential engagements of glutamate and GABA receptors in cardiovascular actions of endogenous nNOS or iNOS at rostral ventrolateral medulla of rats.

Authors:  Samuel H H Chan; Ling-Lin Wang; Julie Y H Chan
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

5.  Nitric oxide modulates the discharge rate of basal forebrain neurons.

Authors:  Andrey Kostin; Dag Stenberg; Anna V Kalinchuk; Tarja Porkka-Heiskanen
Journal:  Psychopharmacology (Berl)       Date:  2008-07-26       Impact factor: 4.530

6.  Nitric oxide alters GABAergic synaptic transmission in cultured hippocampal neurons.

Authors:  Santina Zanelli; Martha Naylor; Jaideep Kapur
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

7.  Nitric oxide, cAMP and the biphasic muscarinic modulation of ACh release at the lizard neuromuscular junction.

Authors:  Austin R Graves; Katherine A Lewin; Clark A Lindgren
Journal:  J Physiol       Date:  2004-07-02       Impact factor: 5.182

8.  Extracts and constituents of Leontopodium alpinum enhance cholinergic transmission: brain ACh increasing and memory improving properties.

Authors:  Ariane Hornick; Stefan Schwaiger; Judith M Rollinger; Nguyen Phung Vo; Helmut Prast; Hermann Stuppner
Journal:  Biochem Pharmacol       Date:  2008-05-03       Impact factor: 5.858

9.  Nitric oxide donors enhance the frequency dependence of dopamine release in nucleus accumbens.

Authors:  Henrike Hartung; Sarah Threlfell; Stephanie J Cragg
Journal:  Neuropsychopharmacology       Date:  2011-04-20       Impact factor: 7.853

10.  Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation.

Authors:  D Centonze; A Pisani; P Bonsi; P Giacomini; G Bernardi; P Calabresi
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.